Cargando…

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Patients with sickle cell disease (SCD) are at high risk of developing serious infections, therefore, understanding the impact that severe acute respiratory syndrome coronavirus 2 infection has on this population is important. We sought to identify factors associated with hospitalization and serious...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mucalo, Lana, Brandow, Amanda M., Dasgupta, Mahua, Mason, Sadie F., Simpson, Pippa M., Singh, Ashima, Taylor, Bradley W., Woods, Katherine J., Yusuf, Fouza I., Panepinto, Julie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248962/ https://www.ncbi.nlm.nih.gov/pubmed/34196678 http://dx.doi.org/10.1182/bloodadvances.2021004288

Ejemplares similares

History of Pain is Associated with Hospitalization and Severe Course of COVID-19 in Children with Sickle Cell Disease
por: Mucalo, Lana, et al.
Publicado: (2021)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020
por: Panepinto, Julie A., et al.
Publicado: (2020)

A perspective on the sickle cell disease international COVID-19 registry
por: Mucalo, Lana, et al.
Publicado: (2022)

Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease
por: Mason, Sadie F., et al.
Publicado: (2023)

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
por: Singh, Ashima, et al.
Publicado: (2020)

COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals
por: Singh, Ashima, et al.
Publicado: (2021)

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
por: Mucalo, Lana, et al.
Publicado: (2023)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
por: Minniti, Caterina P., et al.
Publicado: (2021)

Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
por: Adamkiewicz, Thomas V., et al.
Publicado: (2023)

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
por: Dhar, Arushi, et al.
Publicado: (2021)

Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
por: Ataga, Kenneth I., et al.
Publicado: (2022)

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya
por: McAuley, Charlotte F., et al.
Publicado: (2010)

Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria
por: Henrici, Ryan C., et al.
Publicado: (2021)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
por: Jiao, Boshen, et al.
Publicado: (2023)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests
por: Olaniyan, Halimat S., et al.
Publicado: (2023)

Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial
por: Namazzi, Ruth, et al.
Publicado: (2023)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease
por: Singh, Ashima, et al.
Publicado: (2021)

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
por: Popat, Uday R., et al.
Publicado: (2023)

Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients
por: Mead, Monica, et al.
Publicado: (2022)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
por: Quinn, Charles T., et al.
Publicado: (2022)

A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale
por: Gordon, Max J., et al.
Publicado: (2023)

COVID-19 and venous thromboembolism risk in patients with sickle cell disease
por: Singh, Ashima, et al.
Publicado: (2022)

Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program’s Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study
por: Singh, Ashima, et al.
Publicado: (2023)

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
por: Shouse, Geoffrey, et al.
Publicado: (2023)

Cryptococcus neoformans Coinfection Dampens the TNF-α Response in HIV-1-Infected Human THP-1 Macrophages
por: Kalem, Murat C., et al.
Publicado: (2021)

Psychological and Psychiatric Comorbidities in Youth with Serious Physical Illness
por: Nibras, Sohail, et al.
Publicado: (2022)

Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain
por: Karafin, Matthew S., et al.
Publicado: (2019)

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
por: Haverkos, Bradley, et al.
Publicado: (2023)

Advances in the diagnosis and treatment of sickle cell disease
por: Brandow, A. M., et al.
Publicado: (2022)

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
por: Zayac, Adam S., et al.
Publicado: (2023)

Extreme Dysbiosis of the Microbiome in Critical Illness
por: McDonald, Daniel, et al.
Publicado: (2016)

Neighborhood Environment and Type 2 Diabetes Comorbidity in Serious Mental Illness
por: Walsan, Ramya, et al.
Publicado: (2020)

Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
por: Barnkob, Mike Bogetofte, et al.
Publicado: (2020)

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
por: Hoiland, Ryan L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_km5751m0fjsfuc7q0jvhp5b54d